• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to project page

2001 Fiscal Year Final Research Report Summary

The intracellular signal transduction of granulopoiesis

Research Project

Project/Area Number 11307015
Research Category

Grant-in-Aid for Scientific Research (A)

Allocation TypeSingle-year Grants
Section一般
Research Field Hematology
Research InstitutionKYUSHU UNIVERSITY

Principal Investigator

SHIMODA Kazuya  School of Medicine, University Hospital, Kyushu University, Associate Professor, 医学部・附属病院, 助手 (90311844)

Co-Investigator(Kenkyū-buntansha) OKAMURA Takashi  Kurume University, Faculty of Medicine, Assist Professor, 医学部, 助教授 (30136436)
GONDO Hisashi  School of Medicine, University Hospital, Kyushu University, Associate Professor, 医学部・附属病院, 助手 (10253428)
Project Period (FY) 1999 – 2001
KeywordsTyk2 / G-CSF / TPO / IL-12 / IL-18 / Jak kinase
Research Abstract

Janus kinases (Jaks) play an important role in signal transduction via cytokine receptors. Tyk2 is a Janus kinase, and we developed tyk2-deficient mice to study the requirement for tyk2 in vivo. Tyk2-deficient mice show no overt developmental abnormalities, however they display a lack of responsiveness to a small amount of IFNα, although a high concentration of IFNα can fully transduce its signal even in the absence of tyk2. Furthermore, IL-12-induced T cell function is defective in these mice. In contrast, these mice respond normally to IL-6 and IL-10 both of which activate tyk2 in vitro. These observations demonstrate that tyk2 plays only a restricted role in mediating IFNα-dependent signaling, whilst being required in mediating IL-12- dependent biological responses.
Next we examined whether tyk2 is required for IL-12-induced NK cell activity, as IL-12 is a stimulatory factor for NK cell-mediated cytotoxicity, IL-12-induced NK cell activity in cells from tyk2-deficient mice was drastically reduced compared to that in cells from wild-type mice. IL-18 shares its biological functions with IL-12. However, the molecular mechanism of IL-18 signaling, which activates an 1L-1 receptor-associated kinase and nuclear translocation of nuclear factor _kB, is different from that of IL-12. We next examined whether biological functions induced by IL-18 are affected by the absence of tyk2. NK cell activity and IFNγ production induced by IL-18 were reduced by the absence of tyk2. Moreover the synergistic effect of IL-12 and IL-18 for the production of IFNγ was also abrogated by the absence of tyk2. This was partially due to the absence of any up-regulation of the IL-18 receptor treated with IL-12, and it might suggest the presence of the cross-talk between Jak-Stat and MAP kinase pathways in cytokine signaling.

  • Research Products

    (18 results)

All Other

All Publications (18 results)

  • [Publications] Shimoda K et al.: "Partial impairment of IL-12 and IL-18 signaling in Tyk2-deficient mice"Blood. (in press).

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Kanaji T: "Identification and characterization of two novel mutations (Q421K and R123P) in congenital factor XII deficiency"Thromb Haemos. (in press).

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Yakushiji K et al.: "Monitoring of cytomegalovirus reaction after allogenic stem cell transplantation : comparison of an antigenemia assay and quantitative real-time polymerase chain reaction"Bone Marrow Transplantation. (in press).

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Numata A et al.: "Therapy-related chronic myelogenous leukemia following autologous stem cell transplantation for Ewing's sarcoma"British J Haematol. (in press).

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Okamura T et al.: "Primary chronic myelofibrosis : Clinical and prognostic evaluation in 336 Japanese patients"Int J Hematol. 73. 194-198 (2001)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Asano Y et al.: "Immunosuppressive therapy for patients with refractory anemia"Ann Hematol. 80. 634-638 (2001)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Mizuno S et al.: "Expression of DNA methyiiransferases DNMT1, 3A, and 3B in normal hematopoiesis an in acute and chronic myelogenous leukemia"Blood. 97. 1172-1179 (2001)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Sugio Y et al.: "Ticlopidine-associated thromboticthrombocytopenic purpura with an IgG-ype inhibito to von Willebrandfactor-cleaving protease activity"Int J Hemat. 74. 347-351 (2001)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] 岡村 孝, 仁保 喜之: "Annual Review 血液 2002"骨髄繊維症の病態と治療(in press).

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Shimoda. K, et al: "Partial Impairment of IL-12 and IL-18 Signaling in Tyk2-deficient Mice"Blood. (in press).

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Kanaji. T, et al: "Identification and characterization of two novel mutations (Q421K and R123P) in congenital factor XII deficiency"Thromb Haemos. (in press).

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Yakushiji. K, et al: "Monitoring of cytomegalovirus reaction after allogenic stem cell transplantation : comparison of an antigenemia assay and quantitative real-time polymerase chain reaction"Bone Marrow Transplantation. (in press).

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Numata. A, et al: "Therapy-related chronic myelogenous leukemia following autologous stem cell transplantation for Ewing's sarcoma"British J Haematol. (in press).

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Okamura. T, et al: "Primary chronic myelofibrosis : Clinical and prognostic evaluation in 336 Japanese patients"Int J Hematol. 73. 194-198 (2001)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Asano. Y, et al: "Immunosuppressive therapy for patients with refractory anemia"Annual of Hematology. 80. 634-638 (2001)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Mizuno. S: "Expression of DNA methyltransferases DNMT1, 3A, and 3B in normal hematopoiesis and in acute and chronic myelogenous leukemia"Blood. 97. 1172-1179 (2001)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Sugio. Y: "Ticlopidine-associated thrombotic thrombocytopenic purpura with an IgG-type inhibitor to von Willebrand factor-cleaving protease activity"Int J Hemat. 74. 347-351 (2001)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Okamura T: "The therapy of myelofibrosis"Annual Review Hematology. (in press). (2002)

    • Description
      「研究成果報告書概要(欧文)」より

URL: 

Published: 2003-09-17  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi